Mice infected with M. tuberculosis with Rv0678 mutations still benefit from bedaquiline treatment
Saved in:
| Main Authors: | N. Lounis, T. Gevers, C. Villellas, K. Andries |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
International Union Against Tuberculosis and Lung Disease (The Union)
2024-11-01
|
| Series: | IJTLD Open |
| Subjects: | |
| Online Access: | https://www.ingentaconnect.com/contentone/iuatld/ijtldo/2024/00000001/00000011/art00009 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Investigating the Mutations in atpE and Rv0678 Genes in Mycobacterium Tuberculosis Clinical Isolates
by: Nahid Madadi-Goli1, 2, 3, et al.
Published: (2023-12-01) -
Drug Sensitivity to Bedaquiline of M. kansasii Strains Isolated in Antituberculous Institutions of the City of Moscow
by: M. V. Makarova, et al.
Published: (2023-07-01) -
Impact of rpoB gene mutations and Rifampicin-resistance levels on treatment outcomes in Rifampicin-resistant tuberculosis
by: Maria Jose Vadakunnel, et al.
Published: (2025-02-01) -
Discordance in genotypic and phenotypic drug susceptibility results: time to reconsider critical concentration of rifampicin
by: Arti Shrivas, et al.
Published: (2025-03-01) -
Antimicrobial and cytotoxic evaluation of some herbal essential oils in comparison with common antibiotics in bioassay condition
by: Shahin Gavanji, et al.
Published: (2014-09-01)